Construction, expression, and characterization of a recombinant annexin B1-low molecular weight urokinase chimera in Escherichia coli

Acta Biochimica et Biophysica Sinica

Volumn 36, Issue 3, 2004, Pages 184-190

  Yan, Hong Li ^a   Wang, Wei Ting ^b   He, Yan ^a   Zhao, Zhuan You ^b   Gao, Yuan Jian ^a   Zhang, Yi ^a   Sun, Shu Han ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Annexin B1; Chimera; Low molecular weight single chain urokinase; Thrombolytic agent

Indexed keywords

LOW MOLECULAR WEIGHT PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; CATALYSIS; CHIMERA; CONTROLLED STUDY; ESCHERICHIA COLI; GEL FILTRATION; GENETIC IDENTIFICATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ION EXCHANGE; ION EXCHANGE CHROMATOGRAPHY; MEMBRANE BINDING; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RNA SPLICING;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 2442476372     PISSN: 05829879     EISSN: None     Source Type: Journal    
DOI: 10.1093/abbs/36.3.184     Document Type: Article

References (15)

1. Tanaka K, Einaga K, Tsuchiyama H, Tait JF, Fujikawa K. Preparation and characterization of a disulfide-linked bioconjugate of annexin V with the B-chain of urokinase: An improved fibrinolytic agent targeted to phospholipid-containing thrombi. Biochemistry, 1996, 35(3): 922-9292
2. Yan HL, Sun SH, Chen RW, Guo YJ. Cloning and functional identification of a novel annexin subfamily in Cysticercus cellulosae, Mol Biochem Parasitol, 2002, 119(1): 1-5
3. 2+-dependent phospholipid-binding protein, on coagulation time and thrombosis. Science in China, 2002, 23(4): 378-380
4. Vrkljan M, Foster TM, Powers ME, Henkin J, Porter WR, Staack H., Carpenter JF, Manning MC. Thermal stability of low molecular weight urokinase during heat treatment. II. Effect of polymeric additives. Pharm Res, 1994, 11(7): 1004-1008
5. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual, New York: Cold Spring Harbor Laboratory Press, 2001, 66-87
6. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene, 1989, 77(1): 51-59
7. Marshak DR, Kadonaga JT, Burgess RR, Knuth MW, Brennan WA, Lin SH. Strategies for Protein Purification and Characterization: A Laboratory Course Manual, Cold Spring Harbor Laboratory Press, 1996: 12-45
8. Lenich C, Pannell R, Henkin J, Gurewich V. The influence of glycosylation on the catalytic and fibrinolytic properties of pro-urokinase. Thromb Haemost, 1992, 68(5): 539-544
9. Deckmyn H, Stanssens P. Hoet B, Declerck PJ, Lauwereys M, Gansemans Y, Tornai I et al. An echistatin-like Arg-Gly-Asp(RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function. Br J Haematol, 1994, 87(3): 562-571
10. Zhao ZY, LiuBF, LiuHX, Sun ZY, Zhang J, Liu JNPharmalogical effects of recombinant human prourokinase. Journal of Nanjing University (Natural Sciences), 2001, 37(4): 420-433
11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227(259): 680-685
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72: 248-254
13. Lu SD, Ma QJ, Yu W, Liu DP, Li YX, Lu SX, Zheng DX et al. eds. Current Protocols for Molecular Biology, 2nd ed, Beijing: Peking Union Medical College Publishers, 1999, 380-406
14. Yan HL, Song YL, Liu F, He Y, Sun SH. Homology modeling three-dimensional structure of AnxB1 and reducing the immunogenicity by sequence-deleted mutagenesis. Science in China, 2004, 25(1): 54-60
15. Cahill MR, Newland AC. Platelet activation in coronary artery disease. Br J Biomed Sci, 1993, 50(3): 221-234